{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T13:57:28Z","timestamp":1794405448678,"version":"4.9.0"},"reference-count":79,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,7,15]],"date-time":"2022-07-15T00:00:00Z","timestamp":1657843200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Regenerative Therapy"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1016\/j.reth.2022.07.003","type":"journal-article","created":{"date-parts":[[2022,8,23]],"date-time":"2022-08-23T13:02:32Z","timestamp":1661259752000},"page":"201-209","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":42,"special_numbering":"C","title":["Mesenchymal stem cell therapy: A review of clinical trials for multiple sclerosis"],"prefix":"10.1016","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6401-9347","authenticated-orcid":false,"given":"Asma","family":"Alanazi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9830-0551","authenticated-orcid":false,"given":"Mohammad","family":"Alassiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dunia","family":"Jawdat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaser","family":"Almalik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.reth.2022.07.003_bib1","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1007\/s00109-006-0065-1","article-title":"Antigen presentation in autoimmunity and CNS inflammation: how T lymphocytes recognize the brain","volume":"84","author":"Becher","year":"2006","journal-title":"J\u00a0Mol Med"},{"key":"10.1016\/j.reth.2022.07.003_bib2","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1038\/bmt.2011.208","article-title":"Autologous hematopoietic cell transplantation following high-dose immunosuppressive therapy for advanced multiple sclerosis: long-term results","volume":"47","author":"Bowen","year":"2012","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.reth.2022.07.003_bib3","first-page":"309","article-title":"Mesenchymal stem cell-based therapy in a mouse model of experimental autoimmune encephalomyelitis (EAE)","volume":"1213","author":"Bowles","year":"2014","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.reth.2022.07.003_bib4","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1097\/j.pain.0000000000001429","article-title":"The association between multiple sclerosis and pain medications","volume":"160","author":"Burkill","year":"2019","journal-title":"Pain"},{"key":"10.1016\/j.reth.2022.07.003_bib5","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.stem.2011.06.008","article-title":"The MSC: an injury drugstore","volume":"9","author":"Caplan","year":"2011","journal-title":"Cell Stem Cell"},{"issue":"4","key":"10.1016\/j.reth.2022.07.003_bib6","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1177\/1352458517703802","article-title":"Pilot trial of intravenous autologous culture-expanded mesenchymal stem cell transplantation in multiple sclerosis","volume":"24","author":"Cohen","year":"2018","journal-title":"Mult Scler"},{"key":"10.1016\/j.reth.2022.07.003_bib7","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/1745-6215-12-62","article-title":"The mesenchymal stem cells in multiple sclerosis (MSCIMS) trial protocol and baseline cohort characteristics: an open-label pre-test: post-test study with blinded outcome assessments","volume":"12","author":"Connick","year":"2011","journal-title":"Trials"},{"key":"10.1016\/j.reth.2022.07.003_bib8","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/S1474-4422(11)70305-2","article-title":"Autologous mesenchymal stem cells for the treatment of secondary progressive multiple sclerosis: an open-label phase 2a proof-of-concept study","volume":"11","author":"Connick","year":"2012","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.reth.2022.07.003_bib9","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1046\/j.1440-1711.2002.01118.x","article-title":"Dendritic cells, chemokine receptors, and autoimmune inflammatory diseases","volume":"80","author":"Cravens","year":"2002","journal-title":"Immunol Cell Biol"},{"key":"10.1016\/j.reth.2022.07.003_bib10","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/j.1365-2249.2009.03874.x","article-title":"Cell contact, prostaglandin E(2) and transforming growth factor beta 1 play non-redundant roles in human mesenchymal stem cell induction of CD4+CD25(high) forkhead box P3+ regulatory T cells","volume":"156","author":"English","year":"2009","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.reth.2022.07.003_bib11","article-title":"Adipose-derived mesenchymal stem cells (AdMSC) for the treatment of secondary-progressive multiple sclerosis","author":"Fernandez","year":"2018","journal-title":"Cold Spring Harb Perspect Med"},{"key":"10.1016\/j.reth.2022.07.003_bib12","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1111\/j.1365-2567.2008.02881.x","article-title":"The T-cell pool is energized in patients with multiple sclerosis in remission","volume":"126","author":"Fransson","year":"2009","journal-title":"Immunology"},{"issue":"1","key":"10.1016\/j.reth.2022.07.003_bib13","first-page":"1","article-title":"Multiple sclerosis: pathogenesis, symptoms, diagnoses, and cell-based therapy","volume":"19","author":"Ghasemi","year":"2017","journal-title":"Cell J"},{"key":"10.1016\/j.reth.2022.07.003_bib14","first-page":"251","article-title":"Immunotherapy for neurological diseases, present and future","volume":"42","author":"Ginestal-Lopez","year":"2018","journal-title":"Farm Hosp"},{"key":"10.1016\/j.reth.2022.07.003_bib15","first-page":"175","article-title":"Multiple sclerosis review","volume":"37","author":"Goldenberg","year":"2012","journal-title":"P\u00a0T"},{"key":"10.1016\/j.reth.2022.07.003_bib16","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1111\/j.1600-065X.2011.01016.x","article-title":"Immune tolerance in multiple sclerosis","volume":"241","author":"Goverman","year":"2011","journal-title":"Immunol Rev"},{"key":"10.1016\/j.reth.2022.07.003_bib17","doi-asserted-by":"crossref","first-page":"40133","DOI":"10.1074\/jbc.M111.277814","article-title":"N-acetylglucosamine inhibits T-helper 1 (Th1)\/T-helper 17 (Th17) cell responses and treats experimental autoimmune encephalomyelitis","volume":"286","author":"Grigorian","year":"2011","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.reth.2022.07.003_bib18","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1212\/WNL.0b013e3181e24124","article-title":"Multiple sclerosis, vitamin D, and HLA-DRB1\u221715","volume":"74","author":"Handunnetthi","year":"2010","journal-title":"Neurology"},{"key":"10.1016\/j.reth.2022.07.003_bib19","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1212\/WNL.0000000000001608","article-title":"The cost of multiple sclerosis drugs in the US and the pharmaceutical industry: too big to fail?","volume":"84","author":"Hartung","year":"2015","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.reth.2022.07.003_bib20","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.neuron.2006.09.011","article-title":"The neurobiology of multiple sclerosis: genes, inflammation, and neurodegeneration","volume":"52","author":"Hauser","year":"2006","journal-title":"Neuron"},{"key":"10.1016\/j.reth.2022.07.003_bib21","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/j.micinf.2004.02.020","article-title":"Foxp3: a critical regulator of the development and function of regulatory T cells","volume":"6","author":"Hori","year":"2004","journal-title":"Microb Infect"},{"key":"10.1016\/j.reth.2022.07.003_bib22","doi-asserted-by":"crossref","first-page":"404","DOI":"10.4161\/cam.26941","article-title":"Transplantation of umbilical cord and bone marrow-derived mesenchymal stem cells in a patient with relapsing-remitting multiple sclerosis","volume":"7","author":"Hou","year":"2013","journal-title":"Cell Adhes Migrat"},{"key":"10.1016\/j.reth.2022.07.003_bib23","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1002\/jnr.20522","article-title":"Decreased FOXP3 levels in multiple sclerosis patients","volume":"81","author":"Huan","year":"2005","journal-title":"J\u00a0Neurosci Res"},{"key":"10.1016\/j.reth.2022.07.003_bib24","doi-asserted-by":"crossref","DOI":"10.1111\/cpr.12712","article-title":"Immune modulation by mesenchymal stem cells","volume":"53","author":"Jiang","year":"2020","journal-title":"Cell Prolif"},{"key":"10.1016\/j.reth.2022.07.003_bib25","article-title":"Amelioration of experimental autoimmune encephalomyelitis through transplantation of placental derived mesenchymal stem cells","volume":"7","author":"Jiang","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.reth.2022.07.003_bib26","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1001\/archneurol.2010.248","article-title":"Safety and immunological effects of mesenchymal stem cell transplantation in patients with multiple sclerosis and amyotrophic lateral sclerosis","volume":"67","author":"Karussis","year":"2010","journal-title":"Arch Neurol"},{"issue":"Suppl 1","key":"10.1016\/j.reth.2022.07.003_bib27","first-page":"S2","article-title":"Multiple sclerosis immunology: the healthy immune system vs the MS immune system","volume":"74","author":"Kasper","year":"2010","journal-title":"Neurology"},{"key":"10.1016\/j.reth.2022.07.003_bib28","first-page":"432","article-title":"Stem cells for the treatment of heart failure","volume":"12","author":"Kearns-Jonker","year":"2010","journal-title":"Curr Opin Mol Ther"},{"key":"10.1016\/j.reth.2022.07.003_bib29","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1038\/ni1428","article-title":"Regulatory T cells prevent catastrophic autoimmunity throughout the lifespan of mice","volume":"8","author":"Kim","year":"2007","journal-title":"Nat Immunol"},{"key":"10.1016\/j.reth.2022.07.003_bib30","doi-asserted-by":"crossref","first-page":"556","DOI":"10.4252\/wjsc.v7.i3.556","article-title":"Mesenchymal stem cells in the treatment of inflammatory and autoimmune diseases in experimental animal models","volume":"7","author":"Klinker","year":"2015","journal-title":"World J Stem cells"},{"issue":"4","key":"10.1016\/j.reth.2022.07.003_bib31","first-page":"250","article-title":"Numerical status of CD4+ CD25+ FoxP3+ and CD8+ CD28\u2014 regulatory T cells in multiple sclerosis","volume":"17","author":"Kouchaki","year":"2014","journal-title":"Iran J Basic Med Sci"},{"key":"10.1016\/j.reth.2022.07.003_bib32","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.jneuroim.2006.08.003","article-title":"CD4+CD25+FoxP3+ T lymphocytes fail to suppress myelin basic protein-induced proliferation in patients with multiple sclerosis","volume":"180","author":"Kumar","year":"2006","journal-title":"J\u00a0Neuroimmunol"},{"key":"10.1016\/j.reth.2022.07.003_bib33","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1002\/sctm.20-0239","article-title":"Mesenchymal stromal cells for sepsis and septic shock: lessons for treatment of COVID-19","volume":"9","author":"Laroye","year":"2020","journal-title":"Stem Cells Transl Med"},{"key":"10.1016\/j.reth.2022.07.003_bib34","doi-asserted-by":"crossref","first-page":"703","DOI":"10.3727\/096368913X664577","article-title":"Combination cell therapy using mesenchymal stem cells and regulatory T-cells provides a synergistic immunomodulatory effect associated with reciprocal regulation of TH1\/TH2 and th17\/treg cells in a murine acute graft-versus-host disease model","volume":"23","author":"Lim","year":"2014","journal-title":"Cell Transplant"},{"key":"10.1016\/j.reth.2022.07.003_bib35","first-page":"2516","article-title":"Therapeutic effect of transplanted umbilical cord mesenchymal stem cells in a cynomolgus monkey model of multiple sclerosis","volume":"11","author":"Liu","year":"2019","journal-title":"Am. J. Transl. Res."},{"key":"10.1016\/j.reth.2022.07.003_bib36","article-title":"Human mesenchymal stromal cells enhance the immunomodulatory function of CD8CD28 regulatory T cells","author":"Liu","year":"2014","journal-title":"Cell Mol Immunol"},{"issue":"3","key":"10.1016\/j.reth.2022.07.003_bib37","doi-asserted-by":"crossref","first-page":"409","DOI":"10.2174\/157015911796557911","article-title":"Multiple sclerosis: pathogenesis and treatment","volume":"9","author":"Loma","year":"2011","journal-title":"Curr Neuropharmacol"},{"issue":"18","key":"10.1016\/j.reth.2022.07.003_bib38","doi-asserted-by":"crossref","first-page":"2286","DOI":"10.1089\/ars.2012.5068","article-title":"Multiple sclerosis: molecular mechanisms and therapeutic opportunities","volume":"19","author":"Miljklovic","year":"2013","journal-title":"Antioxidants Redox Signal"},{"key":"10.1016\/j.reth.2022.07.003_bib39","doi-asserted-by":"crossref","first-page":"3747","DOI":"10.1016\/j.febslet.2011.03.064","article-title":"Cytokines and effector T cells subsets causing autoimmune CNS disease","volume":"585","author":"Petermann","year":"2011","journal-title":"FEBS Lett"},{"key":"10.1016\/j.reth.2022.07.003_bib40","first-page":"516","article-title":"Interaction of human mesenchymal stem cells with cells involved in alloantigen-specific immune response favors the differentiation of CD4+ T-cell subsets expressing a regulatory\/suppressive phenotype","volume":"90","author":"Maccario","year":"2005","journal-title":"Haematologica"},{"key":"10.1016\/j.reth.2022.07.003_bib41","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1002\/(SICI)1097-4652(199807)176:1<57::AID-JCP7>3.0.CO;2-7","article-title":"Phenotypic and functional comparison of cultures of marrow-derived mesenchymal stem cells (MSCs) and stromal cells","volume":"176","author":"Majumdar","year":"1998","journal-title":"J\u00a0Cell Physiol"},{"issue":"1","key":"10.1016\/j.reth.2022.07.003_bib42","first-page":"212","article-title":"Umbilical cord mesenchymal stem cell transplantation in the treatment of multiple sclerosis","volume":"10","author":"Meng","year":"2018","journal-title":"Am J Trans Res"},{"issue":"2","key":"10.1016\/j.reth.2022.07.003_bib43","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1007\/s12035-013-8543-2","article-title":"Therapeutic effect of transplanted human Wharton's jelly stem cell-derived oligodendrocyte progenitor cells (hWJ-MSC-derived OPCs) in an animal model of multiple sclerosis","volume":"49","author":"Mikaeli Agha","year":"2014","journal-title":"Mol Neurobiol"},{"key":"10.1016\/j.reth.2022.07.003_bib44","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1038\/ncomms1333","article-title":"Genetics and the environment converge to dysregulate N-glycosylation in multiple sclerosis","volume":"2","author":"Mkhikian","year":"2011","journal-title":"Nat Commun"},{"key":"10.1016\/j.reth.2022.07.003_bib45","series-title":"Cultured adherent cells from marrow can serve as long-lasting precursor cells for bone, cartilage, and lung in irradiated mice","first-page":"4857","volume":"1995","author":"Pereira","year":"1995"},{"key":"10.1016\/j.reth.2022.07.003_bib46","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1080\/14737175.2018.1491309","article-title":"An update on intracerebral stem cell grafts","volume":"18","author":"Neal","year":"2018","journal-title":"Expert Rev Neurother"},{"key":"10.1016\/j.reth.2022.07.003_bib47","first-page":"117","article-title":"Adipose-derived mesenchymal stem cells for treatment of airway injuries in a patient after long-term exposure to sulfur mustard","volume":"19","author":"Nejad-Moghaddam","year":"2017","journal-title":"Cell J"},{"key":"10.1016\/j.reth.2022.07.003_bib48","doi-asserted-by":"crossref","first-page":"513","DOI":"10.3727\/096368912X655064","article-title":"Mesenchymal stem cell population isolated from the subepithelial layer of umbilical cord tissue","volume":"22","author":"Patel","year":"2013","journal-title":"Cell Transplant"},{"key":"10.1016\/j.reth.2022.07.003_bib49","article-title":"Feasibility of mesenchymal stem cell culture expansion for a phase I clinical trial in multiple sclerosis","volume":"4","author":"Planchon","year":"2018","journal-title":"Mult Scler J Exp Transl Clin"},{"key":"10.1016\/j.reth.2022.07.003_bib50","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1000369","article-title":"Expression of the multiple sclerosis-associated MHC class II Allele HLA-DRB1\u22171501 is regulated by vitamin D3","volume":"5","author":"Ramagopalan","year":"2009","journal-title":"PLoS Genet"},{"key":"10.1016\/j.reth.2022.07.003_bib51","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1038\/nri3265","article-title":"The anatomical and cellular basis of immune surveillance in the central nervous system","volume":"12","author":"Ransohoff","year":"2012","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.reth.2022.07.003_bib52","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1186\/s13063-015-0953-1","article-title":"Assessment of bone marrow-derived cellular therapy in progressive multiple sclerosis (ACTiMuS): study protocol for a randomized controlled trial","volume":"16","author":"Rice","year":"2015","journal-title":"Trials"},{"key":"10.1016\/j.reth.2022.07.003_bib53","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2015-009090","article-title":"Repeat infusion of autologous bone marrow cells in multiple sclerosis: protocol for a phase I extension study (SIAMMS-II)","volume":"5","author":"Rice","year":"2015","journal-title":"BMJ Open"},{"key":"10.1016\/j.reth.2022.07.003_bib54","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/s12967-018-1433-7","article-title":"Clinical feasibility of umbilical cord tissue-derived mesenchymal stem cells in the treatment of multiple sclerosis","volume":"16","author":"Riordan","year":"2018","journal-title":"J\u00a0Trans Med"},{"key":"10.1016\/j.reth.2022.07.003_bib55","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1093\/intimm\/dxp095","article-title":"Regulatory T cells: how do they suppress immune responses?","volume":"21","author":"Sakaguchi","year":"2009","journal-title":"Int Immunol"},{"key":"10.1016\/j.reth.2022.07.003_bib56","doi-asserted-by":"crossref","first-page":"2581","DOI":"10.4049\/jimmunol.180.4.2581","article-title":"Mesenchymal stem cells are recruited into wounded skin and contribute to wound repair by transdifferentation into multiple skin cell type","volume":"180","author":"Sasaki","year":"2008","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.reth.2022.07.003_bib57","first-page":"1","article-title":"A\u00a0review on stem cell therapy for multiple sclerosis: special focus on human embryonic stem cells","volume":"11","author":"Shroff","year":"2018","journal-title":"Stem Cells Cloning"},{"key":"10.1016\/j.reth.2022.07.003_bib58","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.tips.2020.06.009","article-title":"Mesenchymal stem cell immunomodulation: mechanisms and therapeutic potential","volume":"41","author":"Song","year":"2020","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.reth.2022.07.003_bib59","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/5302120","article-title":"Clinical application of autologous adipose stem cells in patients with multiple sclerosis: preliminary results","volume":"2016","author":"Stepien","year":"2016","journal-title":"Mediat Inflamm"},{"key":"10.1016\/j.reth.2022.07.003_bib60","doi-asserted-by":"crossref","first-page":"2467","DOI":"10.1002\/art.27548","article-title":"Umbilical cord mesenchymal stem cell transplantation in severe and refractory systemic lupus erythematosus","volume":"62","author":"Sun","year":"2010","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.reth.2022.07.003_bib61","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/1483791","article-title":"Stem cells as potential targets of polyphenols in multiple sclerosis and Alzheimer's disease","volume":"2018","author":"Tandon","year":"2018","journal-title":"BioMed Res Int"},{"key":"10.1016\/j.reth.2022.07.003_bib62","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1038\/icb.2010.47","article-title":"Immunosuppressive properties of human umbilical cord-derived mesenchymal stem cells: role of B7-H1 and Ido","volume":"88","author":"Tipnis","year":"2010","journal-title":"Immunol Cell Biol"},{"key":"10.1016\/j.reth.2022.07.003_bib63","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1161\/hc0102.101442","article-title":"Human mesenchymal stem cells differentiate to a cardiomyocyte phenotype in the adult marine heart","volume":"105","author":"Toma","year":"2002","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.reth.2022.07.003_bib64","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1212\/01.wnl.0000194259.90286.fe","article-title":"Disability progression in multiple sclerosis is slower than previously reported","volume":"66","author":"Tremlett","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.reth.2022.07.003_bib65","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1634\/stemcells.2007-0439","article-title":"Wharton's jelly-derived cells are a primitive stromal cell population","volume":"26","author":"Troyer","year":"2007","journal-title":"Stem Cell"},{"key":"10.1016\/j.reth.2022.07.003_bib66","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1097\/01.TP.0000045055.63901.A9","article-title":"Suppression of allogenic T-cell proliferation by human marrow stromal cells: implications in transplantation","volume":"75","author":"Tse","year":"2003","journal-title":"Transplantation"},{"key":"10.1016\/j.reth.2022.07.003_bib67","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/j.1365-2567.2007.02690.x","article-title":"Compromised CD4+CD25 (high) regulatory T-cell function in patients with relapsing-remitting multiple sclerosis is correlated with a reduced frequency of FOXP3-positive cells and reduced FOXP3 expression at the single-cell level","volume":"123","author":"Venken","year":"2008","journal-title":"Immunology"},{"key":"10.1016\/j.reth.2022.07.003_bib68","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1084\/jem.20031579","article-title":"Loss of functional suppression by CD4+CD25+ regulatory T cells in patients with multiple sclerosis","volume":"199","author":"Viglietta","year":"2004","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.reth.2022.07.003_bib69","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1136\/practneurol-2018-001956","article-title":"Advising patients seeking stem cell interventions for multiple sclerosis","volume":"18","author":"Von Wunster","year":"2018","journal-title":"Practical Neurol"},{"key":"10.1016\/j.reth.2022.07.003_bib70","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.clim.2008.01.019","article-title":"Hyperproduction of IL-23 and IL-17 in patients with systemic lupus erythematosus: implications for Th17-mediated inflammation in auto-immunity","volume":"127","author":"Wong","year":"2008","journal-title":"Clin Immunol"},{"key":"10.1016\/j.reth.2022.07.003_bib71","doi-asserted-by":"crossref","first-page":"9238","DOI":"10.3390\/ijms16059283","article-title":"Mesenchymal stem cells and induced pluripotent stem cells as therapies for multiple sclerosis","volume":"16","author":"Xiao","year":"2015","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.reth.2022.07.003_bib72","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/j.intimp.2013.07.016","article-title":"Comparison of in\u00a0vivo immunomodulatory effects of intravenous and intraperitoneal administration of adipose-tissue mesenchymal stem cells in experimental autoimmune encephalomyelitis (EAE)","volume":"17","author":"Yousefi","year":"2013","journal-title":"Int Immunopharm"},{"key":"10.1016\/j.reth.2022.07.003_bib73","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.imlet.2020.05.005","article-title":"Changes of immune parameters of T lymphocytes and macrophages in EAE mice after BM-MSCs transplantation","volume":"225","author":"Xin","year":"2020","journal-title":"Immunol Lett"},{"key":"10.1016\/j.reth.2022.07.003_bib74","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.yexcr.2014.03.013","article-title":"Immunomodulation of mesenchymal stromal cells on regulatory T cells and its possible mechanism","volume":"324","author":"Yan","year":"2014","journal-title":"Exp Cell Res"},{"issue":"45","key":"10.1016\/j.reth.2022.07.003_bib75","doi-asserted-by":"crossref","first-page":"72537","DOI":"10.18632\/oncotarget.12345","article-title":"Umbilical cord-derived mesenchymal stem cells reversed the suppressive deficiency of T regulatory cells from peripheral blood of patients with multiple sclerosis in a co-culture \u2013 a preliminary study","volume":"7","author":"Yang","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.reth.2022.07.003_bib76","article-title":"Systemic transplantation of human umbilical cord derived mesenchymal stem cells-educated T regulatory cells improved the impaired cognition in abetaPPswew\/PS1dE9 transgenic mice","volume":"8","author":"Yang","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.reth.2022.07.003_bib77","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1002\/cbf.2843","article-title":"Isolation and characterization of mesenchymal stem cells from whole human umbilical cord applying a single enzyme approach","volume":"30","author":"Zhang","year":"2012","journal-title":"Cell Biochem Funct"},{"key":"10.1016\/j.reth.2022.07.003_bib78","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0004226","article-title":"Human\u00a0cord\u00a0blood stem cell-modulated regulatory T lymphocytes reverse\u00a0the\u00a0autoimmune-caused type 1 diabetes in nonobese diabetic (NOD)\u00a0mice","volume":"4","author":"Zhao","year":"2009","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.reth.2022.07.003_bib79","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1182\/blood-2008-05-078154","article-title":"CD4 T cells: fates, functions, and faults","volume":"112","author":"Zhu","year":"2008","journal-title":"Blood"}],"container-title":["Regenerative Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352320422000669?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352320422000669?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T17:41:24Z","timestamp":1762450884000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352320422000669"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":79,"alternative-id":["S2352320422000669"],"URL":"https:\/\/doi.org\/10.1016\/j.reth.2022.07.003","relation":{},"ISSN":["2352-3204"],"issn-type":[{"value":"2352-3204","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mesenchymal stem cell therapy: A review of clinical trials for multiple sclerosis","name":"articletitle","label":"Article Title"},{"value":"Regenerative Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.reth.2022.07.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Japanese Society for Regenerative Medicine. Production and hosting by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}